Compare IDEXX Laboratories, Inc. (IDXX) vs Paycom Software Inc (PAYC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Paycom Software Inc — how do they compare? IDEXX Laboratories, Inc. trades at $571.41 (market cap $46.22B), while Paycom Software Inc trades at $206.16 (market cap $9.57B). The key difference: IDEXX Laboratories, Inc. is far larger — about 4.8× Paycom Software Inc's market cap, and Paycom Software Inc pays a 0.71% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | PAYC | |
|---|---|---|
Market Cap | $46.22B | $9.57B |
Sector | Health | Technology |
52-Week High | $766.68 | $233.89 |
52-Week Low | $526.44 | $113.59 |
Enterprise Value | $47.12B | $10.35B |
Dividend Yield | — | 0.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
Paycom Software (PAYC) trades at $206.16, down 3.42% today but maintains strong fundamentals with consistent earnings beats and robust profitability. The stock shows bullish technical momentum with recent Q2 2026 results exceeding expectations, driven by 10% revenue growth and margin expansion. AI-driven demand and automation savings support management's raised 2026 outlook.
Outlook remains positive with analyst consensus target of $219.22 offering 6% upside. Key risks include valuation multiples above sector averages and competitive pressures. The company's strong cash flow generation and dividend payments provide shareholder value support amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →
